Precision medicine study finds new treatment for untreatable subtype of advanced prostate cancer

Prostate Cancer Foundation| Fri Jul 07 16:18:03 EDT 2017
Precision medicine study finds new treatment for untreatable subtype of advanced prostate cancer

A clinical trial reported on at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that advanced prostate cancer patients whose tumors have a certain combination of mutations may significantly benefit from treatment with platinum chemotherapy.

Not all “chemotherapy” is the same.  Taxane chemotherapy (docetaxel, cabazitaxel) which works by blocking cells from multiplying, is a standard of care for advanced prostate cancer.  Platinum chemotherapy (carbop....

Read at Source
Related News